Skip to main content
Premium Trial:

Request an Annual Quote

CyBio, Promega to Co-Develop High-Throughput Liquid-Handling Apps

NEW YORK (GenomeWeb News) — CyBio and Promega plan to co-develop and co-market new high-throughput liquid-handling applications based on CyBio’s liquid-handling instruments, the company said today.
 
Under the agreement, CyBio and Promega will jointly develop and market validated application protocols for high-throughput screening processes in drug development and life science research.
 
CyBio said its CyBi-Well pipettor and Promega’s MultiTox kits together create a “robust automation solution” that is user-friendly and easy to implement.
 
The collaborators also will automate Promega’s cell-based multiplex-assays, which CyBio said increases “data quality in toxicity studies” of drug compounds.
 
Financial terms of the agreement were not released.

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.